Sessions:
Friday, July 16, 2021
- Session I: Current Approaches to the Management of Heart Failure
- Session II: Electrophysiological Approaches to Heart Failure
- Session III: Surgical Strategies for Heart Failure
Saturday, July 17, 2021
- Session IV: Future Directions in Heart Failure Therapy: Drug Innovation and Late Breaking Trials
- Session V: Clinical Science to Clinical Care – Making it Happen in the CHF Clinic
- Session VI: Clinical Care Workshops
Friday, July 16, 2021
7:45 – 8:30 AM
Evolving the Chronic Heart Failure Treatment Paradigm in Cardiology
Jane E. Wilcox, MD, MSc
Novartis Industry Supported Lecture – Not eligible for CME Credit
8:30 – 8:35 AM
Break & Virtual Exhibits
Session I: Current Approaches to the Management of Heart Failure
Moderator: Kirkwood F. Adams, Jr., MD
8:35 – 8:40 AM
Introduction & Program Overview
Kirkwood F. Adams, Jr., MD
8:40 – 9:00 AM
Clinical Challenges: Therapeutic Concepts in Heart Failure with Preserved EF
Marvin A. Konstam, MD
9:00 – 9:20 AM
CHF With Preserved EF – Classical Trial Data
Peter E. Carson, MD
9:20 – 9:40 AM
HFpEF: Emerging Trial Data Leading Us in Novel Directions
Kavita Sharma, MD
9:40 – 9:55 AM
Break & Virtual Exhibits
9:55 – 10:15 AM
“Old School” But Still Essential Drug Therapies for Heart Failure
Stephanie H. Dunlap, DO
10:15 – 11:00 AM
Optimizing Polypharmacy – Strategies to Resolve Treatment Gaps
Gaps: Moderators: Kirkwood F. Adams, Jr, MD
Speaker: Nancy M. Albert, PhD, RN
Panelists: NH Antagonists: Javed Butler, MD, MPH, MBA Aldo Blockade: Marvin Konstam, MD Hydralazine–Nitrate: Alan B. Miller, MD Diuretics: G. Michael Felker, MD, MHS
11:00 – 11:40 AM
Making Polypharmacy Work in the Clinic – Case Vignettes with Discussion
Case Presenters: Douglas D. Schocken, MD and Sara Paul, DNP
Case Discussants: Stephanie H. Dunlap, DO, Robert L. Page II, PharmD, and Hector O. Ventura, MD
11:40 – 12:30 PM
HOT TOPIC
Expert Panel Discussion: Bench to Bedside in HFpEF: Evaluating Mechanistic and Clinical Evidence
Moderator: Kirkwood F. Adams, Jr., MD
Speakers: Robert J. Mentz, MD
Panelists: Peter P. Liu, MD, David E. Lanfear, MD, MS, Christopher M. O’Connor, MD and Mona Fiuzat, PharmD
12:30 – 1:45 PM
Lunch Break & Virtual Exhibits
Session II: Electrophysiological Approaches to Heart Failure
Moderator: Alan B. Miller, MD
1:45 – 2:05 PM
Cardiac Contractility Modulation Therapy for Heart Failure
Faisal F. Syed, BSc, MBChB
2:05 – 2:25 PM
Electrophysiologist’s Perspective: How Can Implantable Cardiac Rhythm Management Devices Help My Heart Failure Patients?
Anil K. Gehi, MD
2:25 – 2:45 PM
Heart Failure Specialist Perspective: EP Devices – Who, When and What?
Alan B. Miller, MD
Panelists: Anil K. Gehi, MD, and Faisal F. Syed, BSc, MBChB
2:45 – 3:00 PM
Break & Virtual Exhibits
Session III: Surgical Strategies for Heart Failure
Moderator: Patricia P. Chang, MD, MHS
3:00 – 3:20 PM
Ventricular Assist Devices: Latest Strategies for Optimal Clinical Application
Mirnela Byku, MD, PhD
3:20 – 3:40 PM
Mitral Regurgitation: Causes, Natural History, Classic and Novel Interventions
JoAnn Lindenfeld, MD
3:40 – 4:00 PM
Real World Insights on Cardiac Assist Devices and Transplantation
James B. Young, MD
4:00 – 4:35 PM
Surgical Approaches to Advanced Heart Failure: Patient Selection and Timing
Case Presenter: Sudha Jaganathan, MD Case Discussant: Patricia P. Chang, MD, MHS
Panelists: James C. Fang, MD, James B. Young, MD, Mirnela Byku, MD, PhD, Christopher V. Chien, MD, and JoAnn Lindenfeld, MD
4:35 – 5:15 PM
Featured Panel Discussion: Device Options for Fluid Management: Focus on Clinical Application
Moderator: Kirkwood F. Adams, Jr., MD
Speakers: JoAnn Lindenfeld, MD and Christopher V. Chien, MD
Commentary: Patricia P. Chang, MD, MHS and James C. Fang, MD
Saturday, July 17, 2021
Session IV: Future Directions in Heart Failure Therapy: Drug Innovation and Late Breaking Trials
Moderator: Kirkwood F. Adams, Jr., MD
8:35 – 8:40 AM
Update on HFSA 2021
John D. Barnes
8:40 – 9:00 AM
Advances in Diagnosis and Treatment of Cardiac Amyloid: Key Role Novel Drug Therapy
Mathew S. Maurer, MD
9:00 – 9:10 AM
Sudden Death in Cardiac Amyloid
Alan B. Miller, MD
9:10 – 9:25 AM
Clinical Discussion of Nuances in the Management of Cardiac Amyloid
Mathew S. Maurer, MD and Alan B. Miller, MD
9:25 – 9:35 AM
Myosin Modulation: Mavacamten in Obstructive Hypertrophic Cardiomyopathy
Kirkwood F. Adams, Jr., MD
9:35 – 9:55 AM
Guanylate Cyclase Stimulation–Vericiguat: Insights VICTORIA and VITALITY–HFpEF Trials
Robert J. Mentz, MD
9:55 – 10:10 AM
Myosin Modulation: Update on Omecamtive Mecarbil in HFrEF: Latest Galactic-HF Results
Kirkwood F. Adams, Jr., MD
10:10 – 10:20 AM
Break & Virtual Exhibits
10:20 – 10:40 AM
CHF and Diabetes Treatment Intersection – SGLT2 Inhibitors to Improve CV Outcomes
Javed Butler, MD, MPH, MBA
10:40 – 11:00 AM
Update on Novel Therapeutic Approaches to Heart Failure
Barry Greenberg, MD
11:00 – 11:45 AM
Featured Panel
Expert Panel Discussion: Potential Opportunities and Challenges for Novel Therapies as Components of the Polypharmacy of Heart Failure: Latest Clinical Perspectives
Moderator: Kirkwood F. Adams, Jr., MD
Speakers: Clyde W. Yancy, MD, MSc
Panelists: Ileana L. Piña, MD, MPH, David E. Lanfear, MD, MS, Barry Greenberg, MD, Robert J. Mentz, MD, and Javed Butler, MD, MPH
11:45 – 12:45 PM
Lunch Break & Virtual Exhibits
Session V: Clinical Science to Clinical Care – Making it Happen in the CHF Clinic
Moderator: Kirkwood F. Adams, Jr., MD
12:45 – 1:00 PM
Pulmonary Arterial Hypertension: Latest Concepts in Evaluation and Treatment
Lisa J. Rose–Jones, MD
1:00 – 1:15 PM
Atrial Fibrillation: Consequences and Therapeutic Implications in CHF
Anil K. Gehi, MD
1:15 – 1:30 PM
Optimizing Therapy in HF Patients with Sleep Disordered Breathing
William G. Cotts, MD
1:30 – 1:45 PM
Optimizing Care in Heart Failure – Process Matters
Ileana L. Piña, MD, MPH
1:45 – 2:15 PM
The Team Approach to Heart Failure Patient Management
Moderator: Ileana L. Piña, MD, MPH
Panelists: Jana M. Glotzer, MSN, ACNP, Katherine Di Palo, PharmD, Erika Schoenborn, PharmD, and Tammy Long, AGNP
2:15 – 2:30 PM
Break & Virtual Exhibits
Session VI: Clinical Care Workshops
2:30 – 3:00 PM
Nursing Challenges in Caring for the Chronic Heart Failure Patient
Jana M. Glotzer, MSN, ACNP, Sarah Waters, ANP–BC, Carrie Neal, RN, BSN, Tammy Long, AGNP, and Emily Baker, MSN, AGNP–C
3:00 – 3:30 PM
Pharmacotherapeutic Challenges in Treating the Heart Failure Patient
Robert L. Page II, PharmD, Barry E. Bleske, PharmD, and Erika Schoenborn, PharmD
3:30 – 3:50 PM
Optimizing Patient Selection for EP Device and Intervention Therapy
Faisal F. Syed, BSc, MBChB and Matthew Baker, MD
3:50 – 4:20 PM
Advanced and Refractory HF: Individualizing LVAD and Hemodynamic Monitoring Strategies
Robert T. Cole, MD, Elizabeth Volz, MD, Lauren B. Cooper, MD, and Megan Andrews, ANP
4:20 – 4:50 PM
Clinical Update on Cardio–Oncology
Daniel J. Lenihan, MD and Jo Ellen Rodgers, PharmD
4:50 – 5:15 PM
Unusual Cardiomyopathies: Approaches to Evaluation and Management
Mirnela Byku, MD, PhD and Uri Elkayam, MD